These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23847384)

  • 41. Genotypes of the human papillomavirus: relevance to Indian field trials of the vaccine.
    Hariharan I; Pillai MR
    Indian J Med Res; 2009 Sep; 130(3):247-60. PubMed ID: 19901434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Vaccination against cervical cancer and diseases caused by Human Papillomavirus].
    Bornstein J; Tuma R; Zarfati D; Ophir E
    Harefuah; 2007 Oct; 146(10):764-9, 814. PubMed ID: 17990391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPV: diagnosis, prevention, and treatment.
    Hathaway JK
    Clin Obstet Gynecol; 2012 Sep; 55(3):671-80. PubMed ID: 22828099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mothers' preferences and willingness to pay for HPV vaccines in Vinh Long Province, Vietnam.
    Poulos C; Yang JC; Levin C; Van Minh H; Giang KB; Nguyen D
    Soc Sci Med; 2011 Jul; 73(2):226-34. PubMed ID: 21733609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria.
    Ugwu EO; Obi SN; Ezechukwu PC; Okafor II; Ugwu AO
    Niger J Clin Pract; 2013; 16(2):249-52. PubMed ID: 23563471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
    Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G
    Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Development of an HPV vaccine--remaining issues and perspective].
    Kondo K
    Nihon Rinsho; 2009 Jan; 67(1):62-8. PubMed ID: 19177753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [New perspective for cervical cancer prevention based on human papilloma virus].
    Muñoz N
    Biomedica; 2006 Dec; 26(4):471-4. PubMed ID: 17315473
    [No Abstract]   [Full Text] [Related]  

  • 51. Cost-benefit analysis on the HPV vaccine in Medicaid-enrolled females of the Appalachian region of Kentucky.
    Prasad SR; Hill R
    J Ky Med Assoc; 2008 Jun; 106(6):271-6. PubMed ID: 18630037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus vaccine: the beginning of the end for cervical cancer.
    Bornstein J
    Isr Med Assoc J; 2007 Mar; 9(3):156-8. PubMed ID: 17402325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Vaccines for precancer and cancer of uterine cervix. I. Prophylactic HPV vaccines].
    Zlatkov V; Kostova P
    Akush Ginekol (Sofiia); 2007; 46(7):27-31. PubMed ID: 18333418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the human papillomavirus (HPV) vaccine in developing countries.
    Kling M; Zeichner JA
    Int J Dermatol; 2010 Apr; 49(4):377-9. PubMed ID: 20465688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
    Vlădăreanu R; Andrei C
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):144-54. PubMed ID: 17595860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HPV vaccines.
    Stanley M
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):279-93. PubMed ID: 16356772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human papillomavirus vaccines for the treatment of cervical cancer.
    Sin JI
    Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
    Oteng B; Marra F; Lynd LD; Ogilvie G; Patrick D; Marra CA
    Sex Transm Infect; 2011 Feb; 87(1):52-7. PubMed ID: 20956352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.